On July 25, 2025, Revival Healthcare Capital (Revival), an investment firm focused on transformative external innovation partnerships in MedTech, announced a strategic partnership with Olympus Corporation (Olympus), a global healthcare leader committed to making people’s lives healthier, safer, and more fulfilling through advanced medical technologies and solutions. The partnership is aimed at harnessing external innovation to accelerate development and market entry for an endoluminal robotics platform initially targeting gastrointestinal (GI) treatments. Wilson Sonsini Goodrich & Rosati advised Revival on the transaction and on fund matters related to the transaction.
As part of the collaboration, Revival and Olympus co-founded Swan EndoSurgical, Inc. (Swan) and will jointly invest up to $458 million into Swan to develop a purpose-built endoluminal robotics platform which will seek to provide earlier, safer, and more effective treatment of lesions or tumors in the GI tract relative to current therapeutic options. The investment is tied to certain pre-agreed milestone events, with Revival taking a majority equity stake and controlling position alongside significant participation from Olympus. This investment is structured to provide Olympus an option to acquire Swan at a predetermined value while Revival has protective rights if Olympus chooses not to exercise its option.
The Wilson Sonsini team that advised Revival on the transaction included:
Corporate
Matt Lyons
Brandon Middleton-Pratt
Darius Dills
Lucas Sheets
Jordan Hecht
Tanner Kuenneth
Michael Kamer
Technology Transactions
Seth Flaum
Sarah Walker
Aleksandar Vitomirov
Stefan Geirhofer
Fredrick Philantrope
Employee Benefits
Michael Klippert
Michael Montfort
Delaware
Ryan Greecher
Angie Flaherty
Employment
Matt Gorman
Erin Wong
Jason Storck
Corporate Finance
John Mao
Restructuring
Erin Fay
Antitrust
Beau Buffier
Kimberley Biagioli
Regulatory
Eva Yin
Tarek Helou
Josh Gruenspecht
Seth Cowell
Waqas Shahid
Privacy
Demian Ahn
For more information, please see Revival’s press release.
